7:07 am PDL BioPharma acquires $150 mln of Notes due 2029 from Accel 300, a subsidiary of kaleo – HedgeChatter

7:07 am PDL BioPharma acquires $150 mln of Notes due 2029 from Accel 300, a subsidiary of kaleo

08 Apr

7:07 am PDL BioPharma acquires $150 mln of Notes due 2029 from Accel 300, a subsidiary of kaleo

Bystocknews PDLI, stock Comments Off

View todays social media effects on PDLI

View the latest stocks trending across Twitter. Click to view dashboard

See who PDL is hiring next, click here to view

Author